Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2011 1
2012 1
2013 2
2014 7
2015 9
2016 11
2017 4
2018 5
2019 5
2020 6
2021 4
2022 8
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: Meta-Analysis, Review, Systematic Review, in the last 10 years. Clear all
Page 1
Tavaborole.
[No authors listed] [No authors listed] 2018 Dec 3. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2018 Dec 3. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 29999785 Free Books & Documents. Review.
Topical tavaborole has not been studied during breastfeeding. Because blood levels are very low after topical application to the toenails, it is unlikely that a measurable amount of the drug will enter the breastmilk....
Topical tavaborole has not been studied during breastfeeding. Because blood levels are very low after topical application to the toen …
Efinaconazole and Tavaborole.
Poulakos M, Grace Y, Machin JD, Dorval E. Poulakos M, et al. J Pharm Pract. 2017 Apr;30(2):245-255. doi: 10.1177/0897190016630904. Epub 2016 Jul 8. J Pharm Pract. 2017. PMID: 26873506 Review.
PURPOSE: The purpose of this article is to review the safety, efficacy, and role of efinaconazole and tavaborole in the treatment of onychomycosis. SUMMARY: Onychomycosis is a fungal infection of the nail caused by dermatophytes, yeasts, and nondermatophyte fungi. ...The o …
PURPOSE: The purpose of this article is to review the safety, efficacy, and role of efinaconazole and tavaborole in the treatment of …
Tavaborole - a treatment for onychomycosis of the toenails.
Gupta AK, Versteeg SG. Gupta AK, et al. Expert Rev Clin Pharmacol. 2016 Sep;9(9):1145-52. doi: 10.1080/17512433.2016.1206467. Epub 2016 Jul 14. Expert Rev Clin Pharmacol. 2016. PMID: 27347905 Review.
Tavaborole (5%) is FDA approved for treating toenail onychomycosis and has shown antifungal activities against yeast, moulds and dermatophytes. ...Tavaborole may be paired with other therapies to potentially increase cure rates....
Tavaborole (5%) is FDA approved for treating toenail onychomycosis and has shown antifungal activities against yeast, moulds and derm …
Spotlight on tavaborole for the treatment of onychomycosis.
Jinna S, Finch J. Jinna S, et al. Drug Des Devel Ther. 2015 Nov 20;9:6185-90. doi: 10.2147/DDDT.S81944. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26640371 Free PMC article. Review.
Tavaborole is a novel, boron-based anti-fungal agent with greater nail plate penetration than its predecessors, due to its smaller molecular weight. ...In this paper, we review the landscape of topical and systemic treatment of onychomycosis, with particular attention to t …
Tavaborole is a novel, boron-based anti-fungal agent with greater nail plate penetration than its predecessors, due to its smaller mo …
Tavaborole topical solution, 5% for the treatment of toenail onychomycosis.
Zane LT, Plattner J, Chanda S, Coronado D, Merchant T, Alley MR, Gupta AK. Zane LT, et al. Drugs Today (Barc). 2015 Oct;51(10):599-607. doi: 10.1358/dot.2015.51.10.2401004. Drugs Today (Barc). 2015. PMID: 26583302 Review.
Tavaborole topical solution, 5% (tavaborole) is a novel, boron-based, antifungal pharmaceutical agent indicated for treatment of toenail onychomycosis due to the dermatophytes Trichophyton rubrum or Trichophyton mentagrophytes. ...Results from preclinical studies an …
Tavaborole topical solution, 5% (tavaborole) is a novel, boron-based, antifungal pharmaceutical agent indicated for treatment …
Onychomycosis: Treatment and prevention of recurrence.
Lipner SR, Scher RK. Lipner SR, et al. J Am Acad Dermatol. 2019 Apr;80(4):853-867. doi: 10.1016/j.jaad.2018.05.1260. Epub 2018 Jun 28. J Am Acad Dermatol. 2019. PMID: 29959962 Review.
Tavaborole (AN-2690) for the treatment of onychomycosis of the toenail in adults.
Gupta AK, Daigle D. Gupta AK, et al. Expert Rev Anti Infect Ther. 2014 Jul;12(7):735-42. doi: 10.1586/14787210.2014.915738. Epub 2014 Jun 4. Expert Rev Anti Infect Ther. 2014. PMID: 24894552 Review.
Tavaborole has a unique mechanism of action against fungal organisms and retains antifungal properties in the presence of keratin. Tavaborole 5.0% nail solution has shown a favourable safety and efficacy profile in Phase II/III clinical trials and is currently under …
Tavaborole has a unique mechanism of action against fungal organisms and retains antifungal properties in the presence of keratin. …
Tavaborole 5% Solution: A Novel Topical Treatment for Toenail Onychomycosis.
Gupta G, Foley KA, Gupta AK. Gupta G, et al. Skin Therapy Lett. 2015 Nov;20(6):6-9. Skin Therapy Lett. 2015. PMID: 27224843 Free article. Review.
As the first antifungal in a boron-containing class of drugs with a novel mechanism of action, tavaborole is able to penetrate the nail plate more effectively than ciclopirox and amorolfine lacquers. In Phase II/III clinical trials, tavaborole was shown to be safe a …
As the first antifungal in a boron-containing class of drugs with a novel mechanism of action, tavaborole is able to penetrate the na …
Onychomycosis: a review.
Gupta AK, Stec N, Summerbell RC, Shear NH, Piguet V, Tosti A, Piraccini BM. Gupta AK, et al. J Eur Acad Dermatol Venereol. 2020 Sep;34(9):1972-1990. doi: 10.1111/jdv.16394. Epub 2020 Jun 5. J Eur Acad Dermatol Venereol. 2020. PMID: 32239567 Review.
Terbinafine, itraconazole and fluconazole are most commonly used, with new oral antifungals such as fosravuconazole being evaluated. Topical treatments, such as efinaconazole, tavaborole, ciclopirox and amorolfine have less serious side effects, but also have generally low …
Terbinafine, itraconazole and fluconazole are most commonly used, with new oral antifungals such as fosravuconazole being evaluated. Topical …
Tavaborole, Efinaconazole, and Luliconazole: Three New Antimycotic Agents for the Treatment of Dermatophytic Fungi.
Saunders J, Maki K, Koski R, Nybo SE. Saunders J, et al. J Pharm Pract. 2017 Dec;30(6):621-630. doi: 10.1177/0897190016660487. Epub 2016 Aug 3. J Pharm Pract. 2017. PMID: 27488125 Review.
Recently, the Food and Drug Administration (FDA) approved efinaconazole and tavaborole for the treatment of onychomycosis. Additionally, the FDA approved luliconazole for the treatment of tinea pedis, tinea cruris, and tinea corporis. ...
Recently, the Food and Drug Administration (FDA) approved efinaconazole and tavaborole for the treatment of onychomycosis. Additional …
51 results